The global Cell Therapy and Gene Therapy CDMO market was valued at US$ 3120 million in 2023 and is anticipated to reach US$ 11110 million by 2030, witnessing a CAGR of 20.0% during the forecast period 2024-2030.

Cell Therapy and Gene Therapy CDMO Market

Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.

North American market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cell Therapy and Gene Therapy CDMO include Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec and He Yuan Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell Therapy and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy and Gene Therapy CDMO.

Report Scope

The Cell Therapy and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Therapy and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cell Therapy and Gene Therapy CDMO Market Report

Report Metric	Details
Report Name	Cell Therapy and Gene Therapy CDMO Market
Accounted market size in 2023	US$ 3120 million
Forecasted market size in 2030	US$ 11110 million
CAGR	20.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Cell Therapy Gene Therapy
Segment by Application	Clinical Stage Projects Commercialization Stage Projects
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec, He Yuan Biology, GenScript Biotech, Kanglong Chemical, Porton shares, Sano Biologics, Yunzhou Biology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy and Gene Therapy CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell Therapy and Gene Therapy CDMO Market growing?

Ans: The Cell Therapy and Gene Therapy CDMO Market witnessing a CAGR of 20.0% during the forecast period 2024-2030.

What is the Cell Therapy and Gene Therapy CDMO Market size in 2030?

Ans: The Cell Therapy and Gene Therapy CDMO Market size in 2030 will be US$ 11110 million.

Who are the main players in the Cell Therapy and Gene Therapy CDMO Market report?

Ans: The main players in the Cell Therapy and Gene Therapy CDMO Market are Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec, He Yuan Biology, GenScript Biotech, Kanglong Chemical, Porton shares, Sano Biologics, Yunzhou Biology

What are the Application segmentation covered in the Cell Therapy and Gene Therapy CDMO Market report?

Ans: The Applications covered in the Cell Therapy and Gene Therapy CDMO Market report are Clinical Stage Projects, Commercialization Stage Projects

What are the Type segmentation covered in the Cell Therapy and Gene Therapy CDMO Market report?

Ans: The Types covered in the Cell Therapy and Gene Therapy CDMO Market report are Cell Therapy, Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cell Therapy

1.2.3 Gene Therapy

1.3 Market by Application

1.3.1 Global Cell Therapy and Gene Therapy CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Stage Projects

1.3.3 Commercialization Stage Projects

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy and Gene Therapy CDMO Market Perspective (2019-2030)

2.2 Cell Therapy and Gene Therapy CDMO Growth Trends by Region

2.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cell Therapy and Gene Therapy CDMO Historic Market Size by Region (2019-2024)

2.2.3 Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Region (2025-2030)

2.3 Cell Therapy and Gene Therapy CDMO Market Dynamics

2.3.1 Cell Therapy and Gene Therapy CDMO Industry Trends

2.3.2 Cell Therapy and Gene Therapy CDMO Market Drivers

2.3.3 Cell Therapy and Gene Therapy CDMO Market Challenges

2.3.4 Cell Therapy and Gene Therapy CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell Therapy and Gene Therapy CDMO Players by Revenue

3.1.1 Global Top Cell Therapy and Gene Therapy CDMO Players by Revenue (2019-2024)

3.1.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell Therapy and Gene Therapy CDMO Revenue

3.4 Global Cell Therapy and Gene Therapy CDMO Market Concentration Ratio

3.4.1 Global Cell Therapy and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Gene Therapy CDMO Revenue in 2023

3.5 Cell Therapy and Gene Therapy CDMO Key Players Head office and Area Served

3.6 Key Players Cell Therapy and Gene Therapy CDMO Product Solution and Service

3.7 Date of Enter into Cell Therapy and Gene Therapy CDMO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Therapy and Gene Therapy CDMO Breakdown Data by Type

4.1 Global Cell Therapy and Gene Therapy CDMO Historic Market Size by Type (2019-2024)

4.2 Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Type (2025-2030)

5 Cell Therapy and Gene Therapy CDMO Breakdown Data by Application

5.1 Global Cell Therapy and Gene Therapy CDMO Historic Market Size by Application (2019-2024)

5.2 Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cell Therapy and Gene Therapy CDMO Market Size (2019-2030)

6.2 North America Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024)

6.4 North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell Therapy and Gene Therapy CDMO Market Size (2019-2030)

7.2 Europe Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024)

7.4 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size (2019-2030)

8.2 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cell Therapy and Gene Therapy CDMO Market Size (2019-2030)

9.2 Latin America Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024)

9.4 Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size (2019-2030)

10.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza Pharmaceuticals

11.1.1 Lonza Pharmaceuticals Company Detail

11.1.2 Lonza Pharmaceuticals Business Overview

11.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Introduction

11.1.4 Lonza Pharmaceuticals Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.1.5 Lonza Pharmaceuticals Recent Development

11.2 Thermo Fisher

11.2.1 Thermo Fisher Company Detail

11.2.2 Thermo Fisher Business Overview

11.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Introduction

11.2.4 Thermo Fisher Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.2.5 Thermo Fisher Recent Development

11.3 catalent

11.3.1 catalent Company Detail

11.3.2 catalent Business Overview

11.3.3 catalent Cell Therapy and Gene Therapy CDMO Introduction

11.3.4 catalent Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.3.5 catalent Recent Development

11.4 Jubilant LifeSciences

11.4.1 Jubilant LifeSciences Company Detail

11.4.2 Jubilant LifeSciences Business Overview

11.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Introduction

11.4.4 Jubilant LifeSciences Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.4.5 Jubilant LifeSciences Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Detail

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Introduction

11.5.4 Boehringer Ingelheim Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Oxford BioMedica

11.6.1 Oxford BioMedica Company Detail

11.6.2 Oxford BioMedica Business Overview

11.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Introduction

11.6.4 Oxford BioMedica Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.6.5 Oxford BioMedica Recent Development

11.7 Charles River

11.7.1 Charles River Company Detail

11.7.2 Charles River Business Overview

11.7.3 Charles River Cell Therapy and Gene Therapy CDMO Introduction

11.7.4 Charles River Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.7.5 Charles River Recent Development

11.8 WuXi AppTec

11.8.1 WuXi AppTec Company Detail

11.8.2 WuXi AppTec Business Overview

11.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Introduction

11.8.4 WuXi AppTec Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.8.5 WuXi AppTec Recent Development

11.9 He Yuan Biology

11.9.1 He Yuan Biology Company Detail

11.9.2 He Yuan Biology Business Overview

11.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Introduction

11.9.4 He Yuan Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.9.5 He Yuan Biology Recent Development

11.10 GenScript Biotech

11.10.1 GenScript Biotech Company Detail

11.10.2 GenScript Biotech Business Overview

11.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Introduction

11.10.4 GenScript Biotech Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.10.5 GenScript Biotech Recent Development

11.11 Kanglong Chemical

11.11.1 Kanglong Chemical Company Detail

11.11.2 Kanglong Chemical Business Overview

11.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Introduction

11.11.4 Kanglong Chemical Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.11.5 Kanglong Chemical Recent Development

11.12 Porton shares

11.12.1 Porton shares Company Detail

11.12.2 Porton shares Business Overview

11.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Introduction

11.12.4 Porton shares Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.12.5 Porton shares Recent Development

11.13 Sano Biologics

11.13.1 Sano Biologics Company Detail

11.13.2 Sano Biologics Business Overview

11.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Introduction

11.13.4 Sano Biologics Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.13.5 Sano Biologics Recent Development

11.14 Yunzhou Biology

11.14.1 Yunzhou Biology Company Detail

11.14.2 Yunzhou Biology Business Overview

11.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Introduction

11.14.4 Yunzhou Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

11.14.5 Yunzhou Biology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher

Catalent

Jubilant Lifesciences

Charles River

Genscript Biotech

Kanglong Chemical

Lonza Pharmaceuticals

List of Tables

Table 1. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cell Therapy

Table 3. Key Players of Gene Therapy

Table 4. Global Cell Therapy and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2019-2024)

Table 8. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2025-2030)

Table 10. Cell Therapy and Gene Therapy CDMO Market Trends

Table 11. Cell Therapy and Gene Therapy CDMO Market Drivers

Table 12. Cell Therapy and Gene Therapy CDMO Market Challenges

Table 13. Cell Therapy and Gene Therapy CDMO Market Restraints

Table 14. Global Cell Therapy and Gene Therapy CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cell Therapy and Gene Therapy CDMO Market Share by Players (2019-2024)

Table 16. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2023)

Table 17. Ranking of Global Top Cell Therapy and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Cell Therapy and Gene Therapy CDMO Product Solution and Service

Table 21. Date of Enter into Cell Therapy and Gene Therapy CDMO Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2019-2024)

Table 25. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2025-2030)

Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2019-2024)

Table 29. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2025-2030)

Table 31. North America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 46. Lonza Pharmaceuticals Company Detail

Table 47. Lonza Pharmaceuticals Business Overview

Table 48. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product

Table 49. Lonza Pharmaceuticals Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 50. Lonza Pharmaceuticals Recent Development

Table 51. Thermo Fisher Company Detail

Table 52. Thermo Fisher Business Overview

Table 53. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product

Table 54. Thermo Fisher Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 55. Thermo Fisher Recent Development

Table 56. catalent Company Detail

Table 57. catalent Business Overview

Table 58. catalent Cell Therapy and Gene Therapy CDMO Product

Table 59. catalent Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 60. catalent Recent Development

Table 61. Jubilant LifeSciences Company Detail

Table 62. Jubilant LifeSciences Business Overview

Table 63. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product

Table 64. Jubilant LifeSciences Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 65. Jubilant LifeSciences Recent Development

Table 66. Boehringer Ingelheim Company Detail

Table 67. Boehringer Ingelheim Business Overview

Table 68. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product

Table 69. Boehringer Ingelheim Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 70. Boehringer Ingelheim Recent Development

Table 71. Oxford BioMedica Company Detail

Table 72. Oxford BioMedica Business Overview

Table 73. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product

Table 74. Oxford BioMedica Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 75. Oxford BioMedica Recent Development

Table 76. Charles River Company Detail

Table 77. Charles River Business Overview

Table 78. Charles River Cell Therapy and Gene Therapy CDMO Product

Table 79. Charles River Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 80. Charles River Recent Development

Table 81. WuXi AppTec Company Detail

Table 82. WuXi AppTec Business Overview

Table 83. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product

Table 84. WuXi AppTec Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 85. WuXi AppTec Recent Development

Table 86. He Yuan Biology Company Detail

Table 87. He Yuan Biology Business Overview

Table 88. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product

Table 89. He Yuan Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 90. He Yuan Biology Recent Development

Table 91. GenScript Biotech Company Detail

Table 92. GenScript Biotech Business Overview

Table 93. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product

Table 94. GenScript Biotech Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 95. GenScript Biotech Recent Development

Table 96. Kanglong Chemical Company Detail

Table 97. Kanglong Chemical Business Overview

Table 98. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product

Table 99. Kanglong Chemical Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 100. Kanglong Chemical Recent Development

Table 101. Porton shares Company Detail

Table 102. Porton shares Business Overview

Table 103. Porton shares Cell Therapy and Gene Therapy CDMO Product

Table 104. Porton shares Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 105. Porton shares Recent Development

Table 106. Sano Biologics Company Detail

Table 107. Sano Biologics Business Overview

Table 108. Sano Biologics Cell Therapy and Gene Therapy CDMO Product

Table 109. Sano Biologics Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 110. Sano Biologics Recent Development

Table 111. Yunzhou Biology Company Detail

Table 112. Yunzhou Biology Business Overview

Table 113. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product

Table 114. Yunzhou Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 115. Yunzhou Biology Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell Therapy and Gene Therapy CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cell Therapy and Gene Therapy CDMO Market Share by Type: 2023 VS 2030

Figure 3. Cell Therapy Features

Figure 4. Gene Therapy Features

Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Cell Therapy and Gene Therapy CDMO Market Share by Application: 2023 VS 2030

Figure 7. Clinical Stage Projects Case Studies

Figure 8. Commercialization Stage Projects Case Studies

Figure 9. Cell Therapy and Gene Therapy CDMO Report Years Considered

Figure 10. Global Cell Therapy and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Cell Therapy and Gene Therapy CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Cell Therapy and Gene Therapy CDMO Market Share by Region: 2023 VS 2030

Figure 13. Global Cell Therapy and Gene Therapy CDMO Market Share by Players in 2023

Figure 14. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2023

Figure 16. North America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Cell Therapy and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 18. United States Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Cell Therapy and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 22. Germany Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Share by Region (2019-2030)

Figure 30. China Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Cell Therapy and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 38. Mexico Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 42. Turkey Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Lonza Pharmaceuticals Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 45. Thermo Fisher Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 46. catalent Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 47. Jubilant LifeSciences Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 48. Boehringer Ingelheim Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 49. Oxford BioMedica Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 50. Charles River Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 51. WuXi AppTec Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 52. He Yuan Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 53. GenScript Biotech Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 54. Kanglong Chemical Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 55. Porton shares Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 56. Sano Biologics Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 57. Yunzhou Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions